GO:0140063 unmodified histone reader activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0140063 (unmodified histone reader activity) is a molecular function describing proteins that specifically bind histone proteins in their unmodified state, as opposed to binding modified histone marks.
• Unmodified histone readers are essential for interpreting the 'histone code' by recognizing the absence of post-translational modifications, thereby influencing chromatin structure and gene expression.
• Key reader domains capable of binding unmodified histones include PHD fingers, PWWP domains, bromo-adjacent homology (BAH) domains, and SANT domains [3,5,6,8].
• Dysregulation of unmodified histone readers is implicated in multiple myeloma, breast cancer, and other malignancies, making them attractive therapeutic targets [5,7].
• CRISPR-based knockout, point mutation, and knock-in models are powerful tools to dissect the causal roles of unmodified histone reader domains in gene regulation and disease [2,3,5].
• Studying GO:0140063 requires integrating structural biology, genomics, and functional assays such as ChIP-seq, CUT&RUN, and CRISPR screening [1,4].
Description
The packaging of DNA into chromatin relies on histone proteins, which are subject to a vast array of post-translational modifications (PTMs) that collectively form the 'histone code'. While much attention has focused on readers of modified histones, a distinct and equally critical class of proteins specifically recognizes histones in their unmodified state. This activity is captured by the Gene Ontology term GO:0140063, unmodified histone reader activity, defined as a histone reader that specifically binds either to an unmodified histone. These readers act as sensors of the absence of modifications, providing a complementary layer of epigenetic regulation that is essential for proper gene expression, development, and genome stability. Unmodified histone reader activity is mediated by conserved protein domains such as PHD fingers, PWWP domains, bromo-adjacent homology (BAH) domains, and SANT domains, which can discriminate between modified and unmodified histone tails [3,5,6,8]. For example, the PHD1 domain of KDM5A binds unmodified H3 and enables active site remodeling, while the SANT1 domain of EZH2 senses the modification state of the H4 tail [6,8]. The C-terminal PHDVC5HCH tandem domain of NSD2 acts as a combinatorial reader of unmodified H3K4 and tri-methylated H3K27, regulating cell adhesion genes in multiple myeloma. These examples highlight the functional diversity and biological importance of unmodified histone recognition. Understanding GO:0140063 is crucial for researchers because it provides a mechanistic framework for how cells interpret chromatin states and how perturbations in these readers contribute to disease. This article synthesizes authoritative QuickGO data and verified PubMed literature to deliver a research-grade overview of the mechanisms, key genes, disease links, and experimental models relevant to unmodified histone reader activity.
unmodified histone reader activity At A Glance
| GO ID | GO:0140063 |
|---|---|
| GO term | unmodified histone reader activity |
| Ontology | molecular_function |
| Synonym | None |
| Definition | A histone reader that specifically binds either to an unmodified histone. |
| Major function | Specific binding to unmodified histones to regulate chromatin-associated processes. |
| Related domains | PHD fingers, PWWP, BAH, SANT, and tandem PHD domains [3,5,6,8]. |
| Disease relevance | Implicated in multiple myeloma, breast cancer, and other cancers [5,7]. |
| Research methods | CRISPR knockout, point mutation, knock-in, ChIP-seq, structural biology [1,2,3,4,5,6,7,8]. |
What Is GO:0140063?
Unmodified histone reader activity (GO:0140063) is a molecular function in which a protein specifically binds to a histone protein that lacks post-translational modifications. Unlike readers of methylated, acetylated, or phosphorylated histones, these proteins recognize the unmodified state of histone tails or globular domains, thereby translating the absence of specific marks into downstream biological outputs such as chromatin remodeling, transcriptional regulation, or enzymatic activity.
Why Is unmodified histone reader activity Important in Cell Biology?
Unmodified histone reader activity is fundamentally important because it allows cells to detect and respond to the absence of histone modifications, a layer of epigenetic information that is as critical as the presence of marks. These readers are integral to the dynamic regulation of chromatin states, influencing transcription, DNA replication, and repair. Dysregulation of unmodified histone readers has been directly linked to human diseases, including multiple myeloma and breast cancer, underscoring their potential as therapeutic targets and biomarkers [5,7].
• Provides a mechanism for interpreting the 'absence' of histone modifications, complementing readers of modified marks.
• Regulates chromatin structure and gene expression by recruiting or stabilizing chromatin-modifying complexes [3,5].
• Influences cell fate decisions and development through dynamic histone binding [6,8].
• Implicated in oncogenesis, particularly in multiple myeloma and breast cancer [5,7].
• Serves as a target for chemical probes and supramolecular inhibitors that disrupt histone binding.
• Enables sensitive detection of modification states, as shown for the EZH2 SANT1 domain.
• Contributes to positive-feedback regulation of histone demethylases such as KDM5A.
• Essential for understanding combinatorial readout of histone marks in disease contexts.
• Facilitates the design of CRISPR-based models to dissect causal roles in disease [2,3,5].
• Offers opportunities for therapeutic intervention by targeting reader domains [4,7].
What Happens During unmodified histone reader activity?
Recognition of unmodified histone tails
In simple terms: Reader proteins scan histone tails and bind when they find no chemical tags attached.
The first step in unmodified histone reader activity is the specific recognition of histone tails that lack post-translational modifications. Structural studies have revealed that domains such as the PHD finger of KDM5A and the SANT1 domain of EZH2 can directly bind unmodified histone peptides, with binding affinity sensitive to the modification state [6,8]. This recognition often involves aromatic cage residues or electrostatic interactions that discriminate against methylated or acetylated lysines.
Conformational changes and active site remodeling
In simple terms: Binding to unmodified histones can flip a switch inside the reader protein, changing its shape and activity.
Upon binding to unmodified histone H3, some reader proteins undergo conformational changes that remodel their catalytic active sites. For example, the PHD1 domain of the histone demethylase KDM5A binds unmodified H3, leading to active site remodeling that modulates its demethylase activity. This allosteric coupling between histone binding and enzymatic function illustrates how unmodified histone recognition can directly regulate downstream catalytic events [2,6].
Combinatorial readout with other modifications
In simple terms: Some readers simultaneously check for the absence of one mark and the presence of another.
Unmodified histone reader activity can be part of a combinatorial readout mechanism. The C-terminal PHDVC5HCH tandem domain of NSD2 binds unmodified H3K4 and tri-methylated H3K27 simultaneously, integrating both signals to regulate transcription of cell adhesion genes in multiple myeloma. This demonstrates that unmodified histone recognition often occurs in concert with other histone marks to achieve precise gene regulation.
Recruitment of chromatin-modifying complexes
In simple terms: After binding, the reader protein brings in other proteins that change chromatin structure.
Once bound to unmodified histones, reader proteins can recruit chromatin-modifying complexes to target loci. The bromo-adjacent homology (BAH) domains of PBRM1 associate with histone tails and contribute to PBAF-mediated gene regulation, linking unmodified histone binding to ATP-dependent chromatin remodeling. Similarly, TRIM24 links a non-canonical histone signature to breast cancer, highlighting how reader-mediated recruitment impacts disease-associated transcriptional programs.
Regulation by post-translational modifications of the reader
In simple terms: The reader proteins themselves can be chemically modified, which affects how well they bind histones.
Unmodified histone reader activity is regulated by post-translational modifications of the reader proteins themselves. For instance, the histone demethylase KDM5A is regulated by its reader domain through a positive-feedback mechanism, where binding to unmodified histones influences its own modification state and activity. Such regulatory loops ensure dynamic control of chromatin association and function.
Key Genes Involved in GO:0140063 unmodified histone reader activity
The following genes encode proteins with demonstrated unmodified histone reader activity or reader domains that bind unmodified histones, as supported by structural and functional studies.
| Gene | Major Role | Research Relevance |
|---|---|---|
| KDM5A | Histone demethylase with PHD1 domain that binds unmodified H3 and remodels active site. | Regulated by its reader domain via positive feedback; target for cancer therapy [2,6]. |
| NSD2 | C-terminal PHDVC5HCH tandem domain reads unmodified H3K4 and H3K27me3. | Regulates cell adhesion genes in multiple myeloma; disease driver. |
| PBRM1 | BAH domains associate with histone tails in PBAF complex. | Tumor suppressor in renal cell carcinoma; chromatin remodeling. |
| EZH2 | SANT1 domain senses H4 tail modification state. | Polycomb repressive complex 2 subunit; cancer target. |
| TRIM24 | Links non-canonical histone signature to breast cancer. | Oncogenic reader; therapeutic target in breast cancer. |
| KDM5B | PHD finger binds unmodified H3 (inferred from family). | Demethylase involved in development and cancer. |
| KDM5C | PHD finger binds unmodified H3 (inferred from family). | X-linked intellectual disability and cancer. |
| PHF8 | PHD finger binds unmodified H3 (inferred from family). | Histone demethylase linked to X-linked mental retardation. |
| ING4 | PHD finger binds unmodified H3 (inferred from family). | Tumor suppressor in multiple cancers. |
| BAZ2A | PHD finger binds unmodified H3 (inferred from family). | Chromatin remodeling in cancer. |
| BRPF1 | PHD finger binds unmodified H3 (inferred from family). | Component of MOZ/MORF histone acetyltransferase complexes. |
| AIRE | PHD finger binds unmodified H3 (inferred from family). | Autoimmune regulator; mutations cause APECED. |
| CHD4 | PHD fingers bind unmodified H3 (inferred from family). | Nucleosome remodeling in cancer. |
| DNMT3A | PWWP domain binds unmodified H3 (inferred from family). | DNA methylation; mutations in leukemia. |
| DNMT3B | PWWP domain binds unmodified H3 (inferred from family). | DNA methylation; mutations in immunodeficiency. |
| UHRF1 | PHD finger binds unmodified H3 (inferred from family). | Epigenetic regulator in cancer. |
| MLL1 | PHD finger binds unmodified H3 (inferred from family). | Histone methyltransferase in leukemia. |
| NSD1 | PHD finger binds unmodified H3 (inferred from family). | Histone methyltransferase in Sotos syndrome. |
How Is unmodified histone reader activity Regulated?
Unmodified histone reader activity is regulated at multiple levels. The reader proteins themselves can undergo post-translational modifications that alter their histone-binding affinity or specificity. For example, KDM5A is regulated by its reader domain through a positive-feedback mechanism, where binding to unmodified histones modulates its own demethylase activity. Additionally, the availability of unmodified histone substrates is influenced by the opposing activities of histone writers and erasers, creating a dynamic equilibrium that readers interpret. Combinatorial readout with other histone marks, as seen for NSD2, further fine-tunes the regulatory output.
unmodified histone reader activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NSD2 | Multiple myeloma; cell adhesion gene regulation | Knockout and point mutation in myeloma cell lines; ChIP-seq |
| TRIM24 | Breast cancer; oncogenic transcription | Knockout and overexpression in breast cancer cells; xenografts |
| PBRM1 | Renal cell carcinoma; PBAF chromatin remodeling | Knockout in renal cancer cells; BAH domain point mutants |
| EZH2 | Lymphoma and other cancers; Polycomb repression | SANT1 domain knock-in mutations; drug sensitivity assays |
| KDM5A | Cancer; demethylase regulation [2,6] | Reader domain knockout and point mutation; enzymatic assays [2,6] |
Multiple Myeloma
The C-terminal PHDVC5HCH tandem domain of NSD2 acts as a combinatorial reader of unmodified H3K4 and tri-methylated H3K27, regulating transcription of cell adhesion genes in multiple myeloma. Dysregulation of this reader activity contributes to disease pathogenesis, making NSD2 a potential therapeutic target.
Breast Cancer
TRIM24 links a non-canonical histone signature to breast cancer, functioning as an unmodified histone reader that promotes oncogenic transcriptional programs. Targeting the reader domain of TRIM24 may offer a therapeutic strategy for breast cancer.
Other Cancers and Epigenetic Disorders
Mutations in unmodified histone reader domains are associated with various cancers and developmental disorders. For instance, PBRM1 BAH domains contribute to PBAF-mediated gene regulation and are frequently mutated in renal cell carcinoma. EZH2 SANT1 domain mutations alter sensitivity to H4 tail modification state, impacting Polycomb function in cancer.
From unmodified histone reader activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does the reader domain bind unmodified histones in cells? | Tagged knock-in of reader domain with ChIP-seq or CUT&RUN [1,3] |
| What is the catalytic consequence of unmodified histone binding? | Point mutation of key binding residues; enzymatic assays [2,6] |
| Does loss of reader activity affect gene expression? | CRISPR knockout of reader domain; RNA-seq [3,5] |
| Can a disease-associated mutation alter reader specificity? | Knock-in of patient mutations; binding assays [5,8] |
| Does overexpression of the reader drive oncogenesis? | Overexpression in cell lines and mouse models |
| Can chemical probes disrupt reader-histone interaction? | Supramolecular host inhibition assays |
How to Study the unmodified histone reader activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| X-ray crystallography | Atomic structure of reader-histone complex | Visualizing binding interfaces [5,6] |
| ChIP-seq | Genome-wide occupancy of reader proteins | Mapping reader binding sites |
| CUT&RUN | High-resolution chromatin occupancy | Low-abundance reader profiling |
| CRISPR knockout | Loss-of-function phenotype | Testing causal roles [2,3,5] |
| RNA-seq | Transcriptional changes upon perturbation | Gene expression profiling |
| ITC/SPR | Binding affinity and kinetics | Quantifying reader-histone interactions [4,8] |
| Supramolecular inhibition | Disruption of histone binding | Chemical probe development |
| Overexpression | Gain-of-function phenotype | Oncogenic potential |
Structural Biology (X-ray crystallography, NMR, cryo-EM)
Structural techniques are essential to visualize how reader domains bind unmodified histones. For example, crystal structures of the KDM5A PHD1 domain bound to unmodified H3 revealed active site remodeling, and structures of the NSD2 PHDVC5HCH tandem domain elucidated combinatorial readout. These methods provide atomic-level detail for designing mutations and inhibitors.
Genomic Profiling (ChIP-seq, CUT&RUN, ATAC-seq)
Genome-wide profiling of reader occupancy and chromatin accessibility can reveal the functional impact of unmodified histone reader activity. ChIP-seq for PBRM1 BAH domains showed association with histone tails and contribution to PBAF-mediated gene regulation. CUT&RUN offers higher resolution for low-abundance readers.
Functional Genomics (CRISPR knockout, RNAi, overexpression)
CRISPR-based knockout and overexpression are powerful for dissecting the causal roles of unmodified histone readers. Knockout of NSD2 reader domain in multiple myeloma cells altered cell adhesion gene expression, and overexpression of TRIM24 in breast cancer models promoted oncogenesis. These approaches link reader activity to phenotype [2,3,5].
Biochemical and Biophysical Binding Assays
Isothermal titration calorimetry (ITC), surface plasmon resonance (SPR), and fluorescence polarization are used to measure binding affinities between reader domains and unmodified histone peptides. Such assays demonstrated that supramolecular hosts can inhibit histone binding and that EZH2 SANT1 sensitivity depends on H4 tail modification state.
How CRISPR Can Be Used to Study GO:0140063 unmodified histone reader activity
Knockout
CRISPR knockout of genes encoding unmodified histone readers or their reader domains can abolish binding to unmodified histones and reveal loss-of-function phenotypes. For example, knockout of NSD2 in multiple myeloma cells downregulated cell adhesion genes, demonstrating the functional importance of its combinatorial reader activity. Knockout of PBRM1 BAH domains impaired PBAF-mediated gene regulation.
Point Mutation
Point mutations in reader domains can selectively disrupt histone binding without affecting protein stability. Mutating key residues in the KDM5A PHD1 domain abolished unmodified H3 binding and altered demethylase activity. Similarly, point mutations in the EZH2 SANT1 domain changed sensitivity to H4 tail modification state. These models are invaluable for dissecting specific reader functions [2,6,8].
Knock-in
Knock-in of tagged or mutant reader domains allows precise tracking and functional analysis. Tagged knock-in of PBRM1 BAH domains enabled ChIP-seq mapping of their genomic occupancy. Knock-in of disease-associated mutations in NSD2 or EZH2 can model altered reader specificity and its consequences [5,8].
Overexpression
Overexpression of unmodified histone readers can drive oncogenic phenotypes. Overexpression of TRIM24 in breast cancer models promoted tumor growth, linking reader activity to cancer. Overexpression of KDM5A enhanced its demethylase activity through positive feedback. These models help identify therapeutic vulnerabilities [2,7].
How EDITGENE Supports unmodified histone reader activity Research
Researchers studying unmodified histone reader activity-related genes often need to determine whether a candidate gene is causally involved in chromatin regulation or disease. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation of reader domains and their roles in gene expression, disease, and therapeutic response.
Contact EDITGENE today to design your custom CRISPR model for unmodified histone reader activity research.
Frequently Asked Questions About unmodified histone reader activity
What is unmodified histone reader activity?
Unmodified histone reader activity (GO:0140063) is a molecular function where a protein specifically binds to a histone that lacks post-translational modifications, as defined by QuickGO.
What genes are involved in unmodified histone reader activity?
Key genes include KDM5A, NSD2, PBRM1, EZH2, TRIM24, and others encoding PHD, PWWP, BAH, or SANT domains that bind unmodified histones [2,3,5,6,7,8].
How does unmodified histone reader activity differ from modified histone reader activity?
Modified histone readers recognize specific marks like methylation or acetylation, while unmodified histone readers bind histones lacking such marks, often to sense the absence of modifications.
What domains are responsible for unmodified histone reader activity?
Common domains include PHD fingers, PWWP domains, bromo-adjacent homology (BAH) domains, and SANT domains, which can discriminate between modified and unmodified histone tails [3,5,6,8].
Is unmodified histone reader activity linked to cancer?
Yes, dysregulation of readers such as NSD2 in multiple myeloma and TRIM24 in breast cancer has been directly implicated in oncogenesis [5,7].
How can I study unmodified histone reader activity in the lab?
Approaches include structural biology, ChIP-seq, CUT&RUN, CRISPR knockout/knock-in, and biochemical binding assays like ITC or SPR [1,3,4,5,6,8].
What is the role of KDM5A in unmodified histone reader activity?
KDM5A contains a PHD1 domain that binds unmodified H3, leading to active site remodeling and regulation of its demethylase activity through a positive-feedback mechanism [2,6].
Can unmodified histone reader activity be targeted therapeutically?
Yes, small molecules or supramolecular hosts that disrupt reader-histone interactions are being explored as therapeutic strategies, especially in cancer [4,7].
What diseases are associated with unmodified histone reader mutations?
Mutations in readers like NSD2, PBRM1, and EZH2 are associated with multiple myeloma, renal cell carcinoma, and lymphoma, among others [3,5,8].
How does EDITGENE support research on unmodified histone reader activity?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression cell models, library screening, and bioinformatics services to study these readers [2,3,5,6,7,8].
Conclusion
Unmodified histone reader activity (GO:0140063) represents a critical and often underappreciated layer of epigenetic regulation, where proteins specifically recognize histones lacking post-translational modifications to control gene expression and chromatin structure. The diverse reader domains, including PHD fingers, BAH domains, and SANT domains, enable combinatorial and context-dependent readout that is essential for normal development and is frequently dysregulated in cancer [3,5,6,8]. Continued research using CRISPR-based models and advanced genomic techniques will further illuminate the mechanistic and therapeutic relevance of these readers [2,4,7]. EDITGENE offers a comprehensive suite of CRISPR services to accelerate discovery in this field, from knockout and point mutation models to library screening and bioinformatics, empowering researchers to translate unmodified histone reader biology into clinical insights.
References
- 1. Patel DJ et al.. 2013. Readout of epigenetic modifications.. Annu Rev Biochem 82:81-118 PMID: 23642229
- 2. Torres IO et al.. 2015. Histone demethylase KDM5A is regulated by its reader domain through a positive-feedback mechanism.. Nat Commun 6:6204 PMID: 25686748
- 3. Petell CJ et al.. 2023. The bromo-adjacent homology domains of PBRM1 associate with histone tails and contribute to PBAF-mediated gene regulation.. J Biol Chem 299(8):104996 PMID: 37394010
- 4. Allen HF et al.. 2014. Inhibition of histone binding by supramolecular hosts.. Biochem J 459(3):505-12 PMID: 24576085
- 5. Berardi A et al.. 2025. The C-terminal PHDVC5HCH tandem domain of NSD2 is a combinatorial reader of unmodified H3K4 and tri-methylated H3K27 that regulates transcription of cell adhesion genes in multiple myeloma.. Nucleic Acids Res 53(1) PMID: 39656918
- 6. Longbotham JE et al.. 2019. Histone H3 binding to the PHD1 domain of histone demethylase KDM5A enables active site remodeling.. Nat Commun 10(1):94 PMID: 30626866
- 7. Tsai WW et al.. 2010. TRIM24 links a non-canonical histone signature to breast cancer.. Nature 468(7326):927-32 PMID: 21164480
- 8. Weaver TM et al.. 2019. The EZH2 SANT1 domain is a histone reader providing sensitivity to the modification state of the H4 tail.. Sci Rep 9(1):987 PMID: 30700785
